Imexpharm Corp (IMP) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.070x

Based on the latest financial reports, Imexpharm Corp (IMP) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫162.49 Billion ≈ $6.17 Million USD) by net assets (₫2.31 Trillion ≈ $87.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Imexpharm Corp - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Imexpharm Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Imexpharm Corp total liabilities for a breakdown of total debt and financial obligations.

Imexpharm Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imexpharm Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
QST International TWO:8349	0.030x
Kizilbuk Gayrimenkul Yatirim Ortakligi AS IS:KZBGY	0.029x
NEXCOM International Co Ltd TWO:8234	0.017x
NRB Bearing Limited NSE:NRBBEARING	0.128x
29METALS Ltd AU:29M	0.051x
TRANSILVANIA INVESTMENTS ALLIANCE S.A. RO:TRANSI	N/A
Cerro de Pasco Resources Inc. V:CDPR	N/A
Wholetech System Hitech Ltd TWO:3402	0.201x

Annual Cash Flow Conversion Efficiency for Imexpharm Corp (2019–2025)

The table below shows the annual cash flow conversion efficiency of Imexpharm Corp from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Imexpharm Corp.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫2.31 Trillion ≈ $87.63 Million	₫54.17 Billion ≈ $2.06 Million	0.023x	-76.29%
2024-12-31	₫2.18 Trillion ≈ $82.95 Million	₫216.27 Billion ≈ $8.22 Million	0.099x	+610.25%
2023-12-31	₫2.08 Trillion ≈ $79.20 Million	₫-40.47 Billion ≈ $-1.54 Million	-0.019x	-109.71%
2022-12-31	₫1.89 Trillion ≈ $71.98 Million	₫378.60 Billion ≈ $14.38 Million	0.200x	+52.68%
2021-12-31	₫1.79 Trillion ≈ $68.18 Million	₫234.88 Billion ≈ $8.92 Million	0.131x	+209.64%
2020-12-31	₫1.73 Trillion ≈ $65.75 Million	₫73.15 Billion ≈ $2.78 Million	0.042x	-1.04%
2019-12-31	₫1.56 Trillion ≈ $59.23 Million	₫66.59 Billion ≈ $2.53 Million	0.043x	--

About Imexpharm Corp

VN:IMP Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$297.25 Million

₫7.82 Trillion VND

Market Cap Rank

#15004 Global

#86 in Vietnam

Share Price

₫50800.00

Change (1 day)

+6.95%

52-Week Range

₫43500.00 - ₫56700.00

All Time High

₫97000.00